Skip Navigation


Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Chlamydia, a curable sexually transmitted disease (STD), is the most frequently reported bacterial STD in the United States. It is estimated that there are approximately 2.8 million new cases of chlamydia in the United States each year. In 2011, 1,421,791 cases of chlamydial infections were reported to the Centers for Disease Control and Prevention from 50 states and the District of Columbia. Chlamydia cases frequently go undiagnosed and can cause serious problems in men and women, such as penile discharge and infertility respectively, as well as infections in newborn babies of infected mothers.

NIAID Research on Chlamydia

Scientists are looking for better ways to diagnose, treat, and prevent chlamydia. For example, NIAID researchers at the Instiute's Rocky Mountain Laboratories in Hamilton, Montana, are developing a vaccine to prevent Chlamydia trachomatis infection. The vaccine being tested is a single-component vaccine that is designed to protect against all 15 chlamydia varieties. Studies have already shown that the vaccine can prevent laboratory cells from becoming infected.

More NIAID Research on Chlamydia

Last Updated December 11, 2013